French drugmaker Sanofi Pasteur revealed that clinical trials have shown that its new vaccine can protect against three of the four dengue virus strains. The first trials in humans proved the vaccine was safe and represented a key milestone in the quest for a dengue jab, vaccine-maker Sanofi Pasteur executive vice president Michel De Wilde said in a statement. "This is also an important development for global public health, since there is currently no ...via Medindia Health News More READ
No comments:
Post a Comment